Skeletal Muscle Energy Metabolism in Undernourished Patients With Gastrointestinal Cancer
METERMUCADIG
Study of Alterations in Skeletal Muscle Energy Metabolism in Undernourished Patients With Gastrointestinal Cancer
4 other identifiers
interventional
51
1 country
1
Brief Summary
Undernutrition associated with cancer, or cancer cachexia results from a deterioration of the energy balance that leads to a gradual mobilization of energy reserves in the body and to increasing deterioration of the nutritional status of patients. This will thus significantly reduce quality of life and survival of patients with a lower tolerance to cancer treatments. Despite undeniable progress in knowledge, many pathophysiological mechanisms remain few or not explored, which could explain that there is still no satisfactory therapeutic solution to halt the gradual deterioration of the nutritional status of patients. In this sense, apart from preclinical data obtained in animal models, there is currently no clinical study on the functioning of skeletal muscle energy metabolism in undernourished patients suffering of cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 7, 2015
CompletedFirst Posted
Study publicly available on registry
October 12, 2015
CompletedStudy Start
First participant enrolled
January 19, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 4, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 4, 2018
CompletedDecember 22, 2025
December 1, 2025
2.9 years
October 7, 2015
December 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measurement of muscle mitochondrial bioenergetics
Measurement of muscle mitochondrial bioenergetics by high resolution oxygraphy
An average of one week
Secondary Outcomes (4)
Quantification of muscle lipid droplets
An average of one week
Analysis of the expression of target genes and proteins
An average of one week
Determination of body composition (fat mass / lean mass)
Within 4 weeks before inclusion
Determining the isotopic composition of nitrogen hair
An average of one week
Study Arms (2)
Case group
OTHERthe intervention, specific to the study, is to take samples on patients with advanced gastrointestinal cancer
Control group
OTHERthe intervention, specific to the study, is to take samples on non-undernourished patients supported for adjuvant chemotherapy as part of colorectal cancer
Interventions
Eligibility Criteria
You may qualify if:
- years ≤ Age ≤ 80 years
- Colorectal pancreatic cancer
- Undernutrition related to cancer (weight loss \> 5% weight in one month or 10% in 6 months)
- Indication to systemic chemotherapy
- Indication to the development of an implantable port
- Life expectancy ≥ 3 months
- WHO General Status ≤ 2
- Patients affiliated to social security scheme
- Informed consent signed by the patient
You may not qualify if:
- Pregnant or breastfeeding women
- Unbalanced Diabetes
- Systemic corticosteroid treatment
- Any severe uncontrolled medical condition
- Alopecia
- Control group selection criteria:
- years ≤ Age ≤ 80 years
- Colorectal pancreatic cancer
- Indication adjuvant chemotherapy
- Indication to the development of an implantable port
- Life expectancy ≥ 3 months
- WHO General Status ≤ 2
- Patients affiliated to social security scheme
- Informed consent signed by the patient
- Pregnant or breastfeeding women
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service d'Hépato-gastroentérologie et de Cancérologie Digestive, CHRU de TOURS
Tours, 37044, France
Related Publications (1)
Dolly A, Lecomte T, Tabchouri N, Caulet M, Michot N, Anon B, Chautard R, Desvignes Y, Ouaissi M, Fromont-Hankard G, Dumas JF, Servais S. Pectoralis major muscle atrophy is associated with mitochondrial energy wasting in cachectic patients with gastrointestinal cancer. J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1837-1849. doi: 10.1002/jcsm.12984. Epub 2022 Mar 22.
PMID: 35316572RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thierry LECOMTE, MD-PhD
University Hospital, Tours
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2015
First Posted
October 12, 2015
Study Start
January 19, 2016
Primary Completion
December 4, 2018
Study Completion
December 4, 2018
Last Updated
December 22, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share